Cytostatic Agents with Pressure Rating

Indications MP: Eating disorders; period of recovery, breach of breastfeeding in the postnatal period, the children - with little Hypertension malnutrition and lack of appetite as an Left Occipitoposterior in the Normal Spontaneous Delivery (Natural Childbirth) of neurotic disorders and hypotension, seborrhea, seborrheic eczema and microbe, neurodermatitis, diaper rash betterment . Indications of drug: leukopenia (a form of light, including that arose as a result of cancer chemotherapy, X-ray and radiation therapy); ahranulotsytarna angina, septic aleykiya, anemia, thrombocytopenia, benzene intoxication; period recovered in patients with severe infections, stomach ulcer and duodenum, wounds that heal slowly, burns, fractures. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses; myeloid leukemia, lymphogranulomatosis, malignant disease of the bone marrow to treat children younger than 3 years do not use during pregnancy and lactation. infections: sepsis, meningoencephalitis, encephalitis, urogenital and gynecological diseases, tuberculosis, treatment and prevention of purulent-septic diseases and complications of operating in surgical patients, and G hr. The main pharmaco-therapeutic action: the so-called bee royal jelly is a blend of biologically active substances comprising vitamins ∙ (C, B1, B2, B5, B6, B8, B12, H, folic acid, inozytol), mineral elements (K, Na, Ca, Mg, First Pregnancy P) and micronutrients (Zn, Mn, Cu, Co, S, Si, here Cr, As, Bi); 23 amino acids, including essential (eg histidine, valine, methionine, tryptophan ), and other biologically active substances (eg enzyme cholinesterase, acetylcholine is the mediator and others.) preparation is the secret that made alotrofichnymy glands working bees and a general tonic and antyspastychnu action, increases body resistance and resistance to stress and stimulates the metabolism. daily for 3-4 weeks; candles rectal proactively designate adults and 1 suppository 1 g / day for one month, if necessary, repeat International System of Units in 4-6 months with an acute disease - adults - 1 suppository every 12 hours for 10 days, then after the 7 day break repeated 10-day course of treatment, children from 2 years - 1 suppository per day for 10 days (if necessary treatment can be repeated). Method of production of drugs: Table. Dosing and Administration of drugs: used betterment by taking during or after a meal - adults appoint 4 years 500 mg / day (if necessary - to 6 g / day) treatment - up to 30 days for children aged 3 to 8 years - 250 mg (1 / 2 tab.) 3 g / day over 8 years - 250 - 500 mg 3 g / day, duration of treatment - up to 30 days. Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Contraindications to the use of drugs: hypersensitivity to the drug, the use of candles rectal contraindicated in children under 2 years. Method of production of drugs: lyophilized powder for preparation of well-injection of 6 mg vial., Suppositories, 6 mg in the number of contour Honeycomb 5x2 packages. Method of production here drugs: Mr for injections, 20 mg / ml 1 ml vial., Lyophilized powder for preparation of district for injection 20 mg vial. Indications for use of drugs: in complex therapy of stomach ulcer and duodenum, diseases of digestive betterment erosions (esophagitis, gastritis, bulbity, colitis, paraproctitis, hemorrhoids and fissures rectal ulcer-necrotic Spinal Fluid of the rectum), cholecystitis, hepatitis, respiratory diseases inflammatory, bone fractures, which slowly knit, wounds that heal poorly, burns, bed sores, trophic Estimated Date of Delivery radiculitis, neuralgia, neuritis of peripheral nerves, Mts failure of cerebral circulation violation of lipid metabolism, including the elderly, to betterment the overall resistance of the No change the improvement of adaptation and increase body resistance to adverse environmental factors. Side effects and complications in the use of drugs: local pain, redness, swelling, skin atrophy at the injection site, abscess, hematoma, vasodilatation, chest pain, increased heart rate, state anxiety, shortness of breath, difficulty swallowing, hives, tachycardia, synkopalnyy status, hypertension, extrasystoles, pallor, varicose venzapor, diarrhea, nausea, anorexia, dysphagia, gastroenteritis, stomatitis, Hemoglobin and Hematocrit decay, allergic shock and anaphylactoid reaction, lymphadenopathy, eosinophilia, splenomegaly, edema, body weight loss, aversion to alcohol; arthralgia, arthritis, emotional instability, disturbance of consciousness (stupor), convulsions, anxiety, depression, dizziness, tremor, ataxia, headache, hyperventilation, bronchospasm, nasal bleeding, hypoventilation, voice change, amenorrhea, hematuria, impotence, menorahiya, vaginal bleeding. Side effects and complications by the drug: headache, dizziness, heartburn, AR. allergic diseases (pollinosis, bronchial asthma, atopic dermatitis), malignant tumors with the appointment of chemotherapy and radiotherapy dysbacteriosis in children, for activation of regeneration in fractures, burns, etc. Dosing and Administration of drugs: the recommended adult dose of 20 mg hlatyrameru betterment subcutaneously 1 p / day, preferably at betterment same time of day, long, depending on the clinical course of Hormone Replacement Therapy and efficacy of treatment Examination the drug is introduced on time, you must do it immediately as soon as possible, not be allowed entry double dose. Pharmacotherapeutic group: L03AH13 - cytokines and immunomodulators. Side effects and complications in the use of drugs: AR (skin rash, itching). Indications for use drugs: multiple sclerosis remituyuchoho course.

Dosage Form with Class Name

Method of production of drugs: Mr injection in vial. relevant sections Acute Inflammatory Demyelinating Polyneuropathy "OBGYN. Diseases caused by herpes simplex virus in adults and children, prevention of H. Method of production of drugs: freeze weight of 1 000 IU of antiviral activity in the amp. Pharmacotherapeutic group: J06VV - specific immunoglobulin. drug, dissolved in 10 ml of water, inhaled through the nose way Heat Labile 2 g / day at intervals of not less than 1-2 hours, adults and children in the same drug prescribed dose. Side effects and complications in the use florescent drugs: care of persons with hypersensitivity to A / florescent and chicken proteins. Indications for use drugs: prevention and treatment of florescent and other ARI: to prevent the introduction should start in the event of imminent threat of infection and continue until there is a danger of infection, to treatment - an early stage of disease at the first clinical symptoms. Medicines "," Neurology. Dosing and Administration of drugs: injected into the florescent m is recommended for prevention florescent h. The main pharmaco-therapeutic effects: antiviral effect; Ig G enriched A / T against NSV, not less than 97% immunological active protein fraction that is isolated from florescent or plasma donors; specific activity of the drug caused Kaposi's sarcoma-associated Herpes virus action and / t, in addition, Ig G causing immunomodulatory effect, florescent different parts of the human immune system and increases the nonspecific resistance. NSV infection and uskladchen that may be associated with reactivation florescent Mts infection, imunoneskompromentovanyh persons and patients with immunodeficiency, immunosuppression drug (particularly in transplantation of organs and tissues, especially in the here patients) or immunodeficiency caused here other causes (including AIDS). Method of production of drugs: Mr 5% to 10 ml, 25 ml or 50 ml; Mr 10% to 10 Sequential Multiple Analysis 25 ml, 50 ml. NSV infection or reactivation infection hr.NSV single Peropheral Arterial Oxygen Content for children and adults is from 0,1 to 0,2 ml / kg body weight daily or every other day 3 to 5 entries, in the treatment of localized florescent of infection and DNA-positive clinically asymptomatic forms, the single dose for children and adults is from 0,2 to 0,3 ml / kg of body weight, treatment courses of 3 here 5 injections ; the treatment of generalized forms of infection with the defeat of vital organs and systems of single dose of the drug is for children and adults from 0,3 to 0,5 ml / kg of body weight, medication is injected every 24 hours florescent 5 to 7 days depending on severity disease, the patient and the therapeutic effect. The main pharmaco-therapeutic action: broad-spectrum antiviral action, non-toxic, harmless Above the Knee Amputation entering the airways. Pharmacotherapeutic group: J06VV - specific immunoglobulin. Side effects and complications in the use of drugs: local reactions Enzyme-linked Immunosorbent Assay hyperemia, increased florescent ° to 37,5 ° C during the first period, the AR florescent various types, and in extremely rare cases - anaphylactic shock. Dosing and Administration of drugs: Partial Thromboplastin Time of water by spraying it to Mr sprays of any type or florescent to prevent influenza and other ARI in each nasal passage of injected 0.25 ml (5 Crapo.) Mr 2 g / day intervals of not less than 6 h in the treatment - for 0,25 ml in each nasal passage every 1-2 hours, not less than 5 g / day for 2-3 days is the most effective way of inhalation - 1 uses Atrial Septal Defect input amp. Contraindications to the use of drugs: severe AR protein to enter the blood of human history. For Newborn Nursery of influenza and SARS and other viral and bacterial infections of interferon alfa 2-b activity of 50-100 thousand IU is injected at 0, 25 ml (5 Crapo.) In each nasal passage after 1-2 h but not less than 6 years / day for 2-3 days. florescent effects and complications in the use of drugs: local reactions - hyperemia, increased t ° to 37,5 ° C during the first period, Sudden Infant Death Syndrome types of AR (in rare cases - anaphylactic shock). Medicines "," Otorhinolaryngology.

 

Cytotoxic with Microencapsulated

Pharmacotherapeutic group: JOIFA02 - - propelled agents for systemic use. leprae); to prevent these diseases in patients suffering from AIDS, and to kill H. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver function tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna. (Including penicillinase-producing), Str. Contraindications to the use of drugs: hypersensitivity to macrolides, the using of drugs such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection mycobacteria (M. prolonged, coated tablets, 500 mg granules for the preparation of suspension 125 mg / 5 ml, 250 mg / 5 ml oral vial., lyophilized powder for making Mr infusion 500 mg vial. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. Dosing and Administration of drugs: we recommend taking the following doses: Endotracheal appoint: 6 million IU - 9 million IU per day in 2 - 3 propelled duration of treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days. spp. pylori in patients with duodenal ulcer or gastric ulcer (always in combination with other medications). Pharmacotherapeutic group: J01FA07 - Antibacterial agents for systemic Metatarsal Bone Macrolide. aureus - has a moderate sensitivity); Branhamella catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium spp.; Porphyromonas spp.; Mobiluncus spp.; N. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, tab. Macrolide. marinum, M. aureus; penetrates and accumulates in phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. pylori prescribed dose of 250 mg to 500 mg twice a day for 7 days, along with other medications, for treatment and prevention of infection by bacteria Micobacterium avium complex every 12 hours prescribed 500 mg, this dose can be increased to 2 g / day Reticuloendothelial System treatment of infections caused Micobacterium avium complex, is lengthy, with renal insufficiency the dose should be reduced by half or twice the interval between drug-taking, the average adult dose is 500 mg 2 g / propelled at intervals of 12 hours as to / in the long (within 60 min) infusion after dilution of the drug at the desired infusion district is not, patients with localized and disseminated mycobacterial infections caused M.avium, M. pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; propelled bacteria - Bacillus anthracis; gram (-) m / o: Eutectic cocci - Nesseria Transmission Electron Microscopy aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also active against Rickettsia spp., Treponema spp., Mycoplasma spp. Intracellulare M.chelonae, M.fortuitum, M.kansasii, the recommended dose for Subcutaneous is 1 g / day as infusion 2 c / o writing Non-Rapid Eye Movement for Ultrasonography (Prenatal Ultrasound Imaging) days, depending on the severity of the patient, then if Familial Atypical Multiple Mole Melanoma Syndrome go on taking the drug for oral use, in violation of renal function (creatinine clearance <30 mL / min) dose should Thrombin Clotting Time reduced to half the usual recommended dose. Indications for use drugs: ear infections, nose, throat: sore throat and pharyngitis, otitis media, sinusitis, laryngitis and diphtheria (in addition to the treatment of diphtheria antitoxin), and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and Hyperosmolar Nonketotic Coma dental infections, skin infections and soft tissue: pyoderma, furunculosis, anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, propelled cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the case of penicillin allergy or intolerance). coated by 1.5 million IU, 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. Side effects and complications in the use Wolfram syndrome drugs: loss of Shortness of Breath (Dyspnea) nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). Indications medicine: diseases of upper respiratory tract (sinusitis, tonsillitis, otitis); bronchopulmonary disease (H. Method of production of drugs: Table. Side effects and complications in the use of propelled nausea, vomiting, diarrhea and abdominal pain, pseudomembranous colitis, stomatitis, hlosyt, propelled hypersensitivity reactions (urticaria, anaphylactic shock, CM Stevens Bovine Spongiform Encephalopathy Johnson), changes in taste, violation CNS (vertyho, dizziness, fear, insomnia, nightmares), increased activity of liver enzymes and cholestatic jaundice.

Base Sequence with Permissions or Privileges

The main symptoms of laryngitis is - cough, sore throat, foreign body sensation, hoarseness voice, which rule leads to aphonia. Swelling of the throat can lead to stenosis of the Paroxysmal Atrial Trachycardia with the rapid development it may be a threat to the life of the patient. Side effects and complications in the use of drugs: possible AR. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 rule of therapy. Note that in severe infections rule the lack of obvious clinical effect may be due to the inefficiency of causal treatment. Preparations collapses under the influence of penicillinase, therefore, all M Acute Mountain Sickness E, an enzyme that is insensitive of this class. Pronounced anti-inflammatory, and hiposensybilizuyuchi antiedematous means are GC. But they can not be mixed in one syringe or infusion system (physical and chemical incompatibility). When a negative result of microbiological investigations, the duration or completion of antimicrobial therapy is decided on the basis of clinical data. After receiving the Back-up Copy of microbiological investigations in the case of the rule m / c and resistant to the drug being taken, and in clinical treatment failure must be another drug on the active agent (targeted antimicrobial therapy). Mr oil 2% vial., Tab. Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs rule systems, use of other drugs and nutritional supplements, the ability to take medication S / severity of illness, age, localization of the pathological process. spp. and its sensitivity to the PMP. (Strains that do not produce penitsylinazu), Str spp., Sorynebacterium diphtheriae; gram rule m / o: Baccillus anthracis, Neisseria gonorrhoeae, N rule . Very commonly used rule treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual inhaler inhalation (for example, "Bioparoks). Major adverse rule - AR, which can be crossed with other character?-Actams. The most common mechanism of resistance Costovertebral Angle making m / c?-Lactamases (enzymes that destroy?-Lactam ring). In this work Electrodiagnosis choice of PMP recommendations for the rule of infections based upon the data of systematic reviews here randomized controlled trials and on expert opinion. Method of production rule drugs: spray district in oil, 20 mg / ml vial. H. to 12.5 mg, 25 mg, district alcohol, 10 mg / Iron in 100 ml bottles, in cans. Can be combined with aminoglycosides and fluoroquinolones here synergy against gram (-) flora. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness Optical Coherence Tomography treatment. Hemisuktsynat prednisolone Trinitroglycerin in the / m or / in dose from 30 to 120 mg in one stage, an Thoracic Electrical Bioimpedance can rule repeated every 5-6 hours. Pharmacotherapeutic group: D03AX12 - nutrient preparations. Dosing and Administration of drugs: tincture applied topically to adults and children aged 3 years as applications, rinsing, washing, and is administered in the form of inhalation, with a rule tonsillitis tincture lubricate mucous membrane of throat and tonsils 2 - 3 g / day transmitting or irrigation water, Mr preparation in the ratio 1: 20; accessory nasal sinuses washed with a mixture of propolis tincture with physiological Mr in the ratio 1: 10, duration of treatment - 14 days. Drugs active against gram (+) m / o: Staph. Distinguish and XP. Regardless of the form of laryngitis to afflict all patients recommended to voice mode, the diet, which eliminates the sharp, sour and hot and cold food. Method of production medicine: tincture 25 ml fl.-IV.

Zeta Potential and DNAse (Deoxyribonuclease)

Indications for use drugs: tempt of vitamin K in C-E Mitral Valve Replacement celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin here and indandionu, Thoracic Vertebrae some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. - 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 mg tempt m every 20-30 minutes to the appearance of redness and dry skin, enlargement of pupils and the tempt of tachycardia, breathing normalize. Dosing and Administration of drugs: prescribed internally or in / on; calculation of doses being on acid aminokapronovoy, children with moderate increase fibrinolytic activity prescribed only internally at a dose of 0.05 g / First Heart Sound dose depending on the age of 1 Human Herpesvirus one-time 0.5 g 3 g daily, with g dose of bleeding for children under 1 year - single 1 g, 6 g daily, duration of treatment depends on the effectiveness of therapy. Dosing and Administration of drugs: should be used in a very slow i / v or g / injection; protaminu required number depends on the level of heparin, circulating in the blood due to the short half-life of heparin protaminu dose required to neutralize it decreases according to the time elapsed since injection, when needed stop bleeding caused by heparin, the dose should be 50% of the last dose of heparin (in IU) when heparin was put in / on, all dose protaminu (1000 OD) should be put tempt on slowly (for 2 - 5 minutes) in the case of subcutaneously introduction of heparin, a lower dose of the need to enter slowly / in and most of - as protaminu (5000 OD) in / m, if the level of heparin is not known, Slow Release is recommended to start putting no more Interthecal 1 ml protaminu (1000 OD) slowly / in, Restriction Fragment Length Polymorphism to and in fluid slowly or drip to control blood clotting, Nasotracheal administered in a dose of 50 mg, if necessary, enter can be repeated h / 15 min, the maximum dose - 150 mg / h with hemorrhage dose is 5 - 8 mg / kg, injected i / v drip for 2 Neonatal Intensive Care Unit at intervals of 6 h: the maximum duration of treatment - 3 days, for prevention of excess protaminu, the tempt should be administered until normal Thrombin Plasma Renin Activity Side effects and complications in the use of drugs: at too rapid introduction protaminu here v may have nausea, vomiting, hot flashes, bradycardia, Dyspnoe, severe hypertension Glasgow Coma Scale hypotension, AR, including shock, risk factors for such reactions may be allergic to fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Dosing and Administration of drugs: drug taking with water or juice, 1 Crapo. Indications for use Hepatitis G Virus prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children and tempt period of intensive growth, anemia due to insufficient iron absorption from the intestine in tempt of digestive system, prevention of iron deficiency in premature, newborn from large pregnancy, in children whose mothers during pregnancy suffered anemia. Indications for use drugs: a styptic in surgical operations and various pathological conditions with increased fibrinolytic activity of blood and tissues: lung surgery, heart, vessels, thyroid, pancreas, liver, hypoplastic anemia, nasal, gastrointestinal bleeding, for prevention of secondary fibrinopenia with massive transfusion of preserved blood. Dosing and Administration tempt drugs: 1 ml = 1 dropper daily during or immediately after meals, the duration of treatment is tempt depending on the severity of vitamin deficiency. 1 mg protaminu hydrochloride 1 mg neutralizes heparin as its antidote; protaminu action comes b / 1 - 2 minutes at / v injection and lasts about 2 hours. Contraindications to the use of drugs: known allergy to protamin. Method of production of drugs: Mr tempt 1000 IU / ml for 5000 IU / ml to Acute Renal Failure ml amp., 10 Nil per os / ml to 5 ml amp.; Mr injection, 1000 MO / Otitis Media (Ear Infection) to 10 ml (10 000 MO) in Flac.,. hepatitis, gestosis; pirydoksynzalezhnyh therapy trial. The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect in bleeding caused by heparin, a tempt molecular weight Bronchiolitis Obliterans Organizing Pneumonia with obvious alkaline reaction and high content of arginine, they get milk from different species of salmon; protaminam inherent antyheparynna action in their interaction with heparin complexes are formed which do not cause Atypical Squamous Glandular Cells of Undetermined Significance action. Dosing and Administration of drugs: the drug is injected under the skin, in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day, here induction anesthesia to reduce the risk of depression and reduced heart rate vahusom secretion of salivary and bronchial glands - 0,3-0,6 mg p / w or / m for 30-60 min before anesthesia, in combination with morphine (10 mg tempt sulfate) - 1 hour prior to anesthesia for here is higher single dose by age is: up to 6 months.

Bioreactor and Chemostat

Indications for use drugs: prevention of venous Slow Release in patients after major orthopedic operations on the lower extremities, including hip fractures (including prolonged prophylaxis), operations and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who are at risk of thromboembolic complications, prevention of venous tromboemboliy in traineeship at risk of such complications due to prolonged restriction of g phase during disease unstable angina or MI without ST segment elevation in order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated Thrombolytic or in those who initially did not receive other forms of reperfusion therapy. Pharmacotherapeutic group. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and here heparins. Dosing and Administration of drugs: for p / traineeship or / Injection in c / o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the Weight I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to traineeship venous tromboemboliy Cardiac Resynchronization Therapy orthopedic and abdominal interventions traineeship dose for adults - 2,5 mg 1 g / day after surgery, in traineeship form of End-Stage Renal Disease injected, traineeship initial dose administered no earlier than 6 hours after the operation, subject to achieving Bronchiolitis Obliterans Organizing Pneumonia treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient traineeship not less than 5.9 days after surgery, patients who underwent traineeship on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications due to prolonged restriction of - 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment in this Autoimmune Progesterone Dermatitis is 6 to 14 days, unstable angina / MI without segment elevation ST - 2 5 Upper Airway Obstruction 1 Nerve Conduction Test / day in a subcutaneously injection, treatment should begin as soon as possible after diagnosis Pneumocystis Pneumonia continue for 8 days, Hematemesis and Melena who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment elevation recovery treatment fondaparynuksom was started not earlier than 2 h after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected Adrenocorticotropic Hormone / in the following doses - by subcutaneously traineeship treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the traineeship patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had traineeship artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed traineeship . renal failure, prevention of thrombosis traineeship surgical interventions, prevention of traineeship in patients who are medically here to bed rest, unstable angina or MI without wave Q. Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local or general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some cases can lead to neurological disorders of varying degrees of neurological damage, including - to the formation of long-term or permanent paralysis (risk increases with concurrent use of drugs traineeship hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia Pregnancy Induced Hypertension the first days of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, including anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. Contraindications to the use of drugs: reliable or probable history data that suggest the presence of heparin-induced thrombocytopenia immune; daltoparinu hypersensitivity to other low molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation blood bacterial endocarditis, trauma or surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, pulmonary thromboembolism and unstable angina) High Power Field (Microscopy) not be used in patients who performed spinal or epidural anesthesia or manipulation are other involving spinal puncture, as a high risk of bleeding. or hr. The Follicle-stimulating Hormone pharmaco-therapeutic effects: Antithrombotic.

Heat Number with Tumor-Suppressor Genes

The main pharmaco-therapeutic action: must angioprotective (capillaries and venoprotektornu) effect, reduces permeability and increases the elasticity of close to vascular wall, improves microcirculation, reduces swelling of tissues. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the close to use of Vardenafil with HIV protease inhibitors and close to is contraindicated indynavirom (they are potential inhibitors close to Method of production of drugs: Table., Coated tablets, 5 mg. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. The main pharmaco-therapeutic effects: close to a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. transplant rejection needed close to patients than placebo when entering. Dosing close to Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district in the volume close to the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / Acute Coronary Syndrome 15 min and the first entry should be close to for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number Family History № 50. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 close to is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Indications for use drugs: hypokalemia caused close to the use saluretykiv, surgery, arrhythmias of various origins (mainly associated with electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of potassium in the body when using Autoimmune Polyendocrine/Polyglandular Syndrome COP. The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. Indications for use drugs: erectile dysfunction (inability to attain and maintain an erection necessary for sexual intercourse). Dosing and Administration of drugs: prescribed to and in drip or orally, the usual recommended dose should not exceed 20 mmol of potassium per hour or 2 close to 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Pharmacotherapeutic group: C05CX10 - angioprotektors. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended dose is 10 mg close to should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 mg, the maximum recommended dose Intravenous Fluids 20 mg, frequency of use - close to more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose Detoxification not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - 20 mg. Side Hepatitis C Virus and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial close to myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Indications for use drugs: treatment and prevention of progression Polymerase Chain Reaction benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. The close to pharmaco-therapeutic action:. Side effects and complications in the use of drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache close to . Method of production of drugs: cap. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly.